Fierce Competition in the Diabetes Drug Market
Fierce Competition in the Diabetes Drug Market Motley Fool
View ArticleTen rivals join with NIH to search for new drugs - WSJ
Ten rivals join with NIH to search for new drugs - WSJ Yahoo/Reuters
View ArticleA key Actos trial revs up in Vegas with demands for a $1B-plus judgment
A key Actos trial revs up in Vegas with demands for a $1B-plus judgment Fierce Pharma
View ArticleTakeda gets positive CHMP opinion for Entyvio for UC and Crohn’s disease
Takeda gets positive CHMP opinion for Entyvio for UC and Crohn’s disease The Pharma Letter
View ArticleMakings of a Wide Moat in Diabetes Care
Makings of a Wide Moat in Diabetes Care Morningstar
View ArticleTakeda Showed Disregard in Handling Diabetes Drug, Jury Told
Takeda Showed Disregard in Handling Diabetes Drug, Jury Told Bloomberg
View ArticleUS jury hits Takeda, Eli Lilly with $9 bln penalty
US jury hits Takeda, Eli Lilly with $9 bln penalty Yahoo/AP
View ArticleInvestors realize that Lilly won’t lose money in product liability case
Investors realize that Lilly won’t lose money in product liability case Marketwatch
View ArticleNo Legwork Mondays – Takeda, Eli Lilly, And Actos
No Legwork Mondays – Takeda, Eli Lilly, And Actos Yahoo/Benzinga
View ArticleTakeda not interested in synergy or tax-driven M&A - CFO
Takeda not interested in synergy or tax-driven M&A - CFO Yahoo/Reuters
View ArticleTakeda phase 3 trial data shows orteronel plus prednisone improved...
Takeda phase 3 trial data shows orteronel plus prednisone improved progression free survival in men with chemotherapy Pharmabiz
View ArticleTakeda Hid Diabetes Medicine’s Cancer Risks, Jury Is Told
Takeda Hid Diabetes Medicine’s Cancer Risks, Jury Is Told Bloomberg
View ArticleTakeda Denies Hiding Diabetes Drug Risks in Nevada Trial
Takeda Denies Hiding Diabetes Drug Risks in Nevada Trial Bloomberg
View ArticleTakeda’s Bowel Disease Drug Approved by U.S. Regulators
Takeda’s Bowel Disease Drug Approved by U.S. Regulators Bloomberg
View ArticleFirstWord List: Top 15 pharma and lead product dependency
FirstWord List: Top 15 pharma and lead product dependency First Word Pharma
View ArticleAffymax and Takeda Announce Termination of Omontys (peginesatide) Product...
Affymax and Takeda Announce Termination of Omontys (peginesatide) Product Collaboration and License Agreement Pipeline Review
View ArticleTakeda's chief-in-waiting sees big M&A in the drugmaker's future
Takeda's chief-in-waiting sees big M&A in the drugmaker's future Fierce Biotech
View ArticleGerman database study hints diabetes drug cuts Alzheimer's risk
German database study hints diabetes drug cuts Alzheimer's risk Yahoo/Reuters
View ArticleDrugmakers to share neglected compounds with British academia
Drugmakers to share neglected compounds with British academia Yahoo/Reuters
View ArticleTakeda to Extend Global Reach
Takeda to Extend Global Reach Drug Discovery and Development
View Article
